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Fifty years ago, Rachel Carson warned about 
the toxicity of pesticides, including organo-
phosphate (OP) insecticides, in her book Silent 
Spring (Carson 1962). In particular, Carson 
warned that pesticides were toxic. Despite 
these warnings, there have been few attempts 
to study the consequences of fetal exposures 
to organophosphate insecticides until recently, 
when several epidemiologic studies using uri-
nary pesticide metabolites have begun to raise 
concerns about adverse health effects of expo-
sure (Bouchard et al. 2011; Engel et al. 2007, 
2011; Eskenazi et al. 2004; Marks et al. 2010; 
Rauh et al. 2011). Although OP insecticide 
use in the United States has declined, the 
vast majority of people in the United States, 
including pregnant women and children, 
are routinely exposed (Bouchard et al. 2010; 
Woodruff et al. 2011).
The developing fetus may be especially vul-
nerable to OP pesticides because of its small 
size, rapid growth and development, and lim-
ited ability to detoxify harmful substances 
(Eskenazi et al. 1999). Animal studies sug-
gest that prenatal OP insecticide exposure at 
levels higher than those typically encountered 
by humans reduces fetal growth (Spyker and 
Avery 1977; Srivastava and Raizada 1996). 
However, results from several epidemiologic 
studies that sampled from different racial and 
ethnic populations have been inconclusive. 
Among African-American and Dominican 
mothers living in New York City, Whyatt 
et al. (2004) reported an inverse association 
between cord blood concentrations of chlorpy-
rifos, an OP insecticide, with birth length and 
birth weight. In a cohort of primarily Mexican-
American mothers, Eskenazi et al. (2004) 
reported an association between prenatal uri-
nary dialkyl phosphate (DAP) concentrations, 
which are metabolites of OP insecticides, and 
shortened gestation, but not gestation-adjusted 
birth weight.
Paraoxonase (PON) is an enzyme that 
detoxifies several OP pesticides, including 
chlorpyrifos, parathion, and diazinon (Costa 
et al. 2003). Several polymorphisms in the 
PON1 gene affect the function, production, 
and efficiency of PON in the body; recent 
studies have focused on two alleles: PON1192 
and PON1–108 (Costa et al. 2003; Deakin 
et al. 2003). Briefly, a change in the promoter 
region of PON1–108 from the C allele to the 
T allele causes decreased PON production, 
and a change in the coding region of PON1192 
from the R to the Q allele decreases PON’s 
efficiency at detoxifying certain pesticides 
(Costa et al. 2003). In epidemiologic studies, 
results have been inconclusive: Harley et al. 
(2011) found larger DAP-associated reduc-
tions in birth weight and gestational age in 
infants with PON1–108TT genotype (vs. 
PON1–108CC); for PON1192, they found DAP-
associated reductions in gestational age for QQ 
infants, and weaker associations for the RR 
or QR groups. However, Wolff et al. (2007) 
identified PON1192RR as the more susceptible 
group, reporting stronger negative associa-
tions between diethyl alkyl phosphate (DEAP) 
metabolites and birth weight, and between 
dimethyl alkyl phosphate (DMAP) metabo-
lites and birth length, in mothers with the 
PON1192RR genotype (compared with those 
with QQ genotype). Berkowitz et al. (2004) 
found no overall relationship between a urinary 
chlorpyrifos metabolite (3,5,6-trichloropyri-
dinol) and gestational age, birth weight, and 
birth length, but they found an inverse associa-
tion with head circumference when stratifying 
by tertiles of maternal paraoxonase activity.
In the United States, black children are 
more likely than white children to be born 
preterm (gestation < 37 weeks) and to be low 
birth weight (< 2,500 g), both of which place 
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Background: Prenatal exposure to organophosphate (OP) insecticides, a widely used class of 
 pesticides, may be associated with decreased gestational age and lower birth weight. Single nucleo­
tide polymorphisms in paroxanase (PON1) enzyme genotypes may modify the relationships 
between OP exposure and perinatal outcomes.
oBjective: We examined the relationship of prenatal OP insecticide exposure, measured using 
 urinary dialkyl phosphate (DAP) metabolite concentrations, with gestational age and birth weight.
Methods: We measured the concentrations of six nonspecific DAP metabolites of OP insecticides 
in two maternal spot urine samples collected in a prospective birth cohort. We performed multi­
variable regression to examine associations between the sum of six DAP concentrations (ΣDAP) 
with gestational age and birth weight. We also examined whether these associations differed accord­
ing to infant PON1192 and PON1–108 genotypes.
results: Among 306 mother–infant dyads, a 10­fold increase in ΣDAP concentrations was associ­
ated with a decrease in covariate­adjusted gestational age [–0.5 weeks; 95% confidence interval (CI): 
–0.8, –0.1] and birth weight (–151 g; CI: –287, –16); the decrements in birth weight were attenu­
ated after adjusting for gestational age. The relationship between ΣDAP concentrations and gesta­
tional age was stronger for white (–0.7 weeks; CI: –1.1, –0.3) than for black (–0.1 weeks; 95% CI: 
–0.9, 0.6) newborns. In contrast, there was a greater decrease in birth weight with increasing urinary 
ΣDAP concentrations for black (–188 g; CI: –395, 19) than for white (–118 g; CI: –296, 60) new­
borns. Decrements in birth weight and gestational age associated with ΣDAP concentrations were 
greatest among infants with PON1192QR and PON–108CT genotypes.
conclusions: Prenatal urinary ΣDAP concentrations were associated with shortened gestation 
and reduced birth weight in this cohort, but the effects differed by race/ethnicity and PON1192/108 
genotypes.
key words: birth weight, DAPs, fetal growth, gestational age, OPs, organophosphate, paraoxanase, 
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newborns at risk for adverse health outcomes 
(Wise et al. 1985). Racial differences in ges-
tational age and birth weight may be a result 
of adverse environmental exposures, genetics, 
socioeconomic status, and/or other unidenti-
fied factors. Several studies in the United States 
have found that black individuals are often 
exposed to higher levels of environmental toxi-
cants than white individuals, but it is unclear 
whether these exposures contribute to racial 
differences in gestational age or birth weight 
(Gee and Payne-Sturges 2004). There is also 
evidence that PON1 distributions differ across 
racial groups (Davis et al. 2009).
The purpose of this study was to exam-
ine the relationship of prenatal OP insecticide 
exposure, measured using urinary concentra-
tions of six DAP metabolites, with gestational 
age and birth weight in a birth cohort from 
Cincinnati, Ohio. We hypothesized that ges-
tational OP exposure would be associated with 
shorter gestation and lower birth weight. We 
also hypothesized that the relationship between 
urinary OP exposure and birth weight/ 
gestational age would be greatest among infants 
with PON1192QQ or PON1–108TT genotypes.
Methods
Study sample. We used data collected from 
mothers and newborns enrolled in the Health 
Outcomes and Measures of the Environment 
(HOME) Study, an ongoing prospective birth 
cohort. Subject recruitment and interviews for 
the HOME Study have been described else-
where (Braun et al. 2010). Briefly, we identi-
fied and contacted women attending seven 
prenatal clinics in the Cincinnati metropoli-
tan area between March 2003 and January 
2006. Eligibility criteria included being at least 
18 years of age; living in a home built before 
1978; ≤ 19 weeks of gestation; being HIV neg-
ative; living within five surrounding counties; 
and not receiving thyroid or seizure medica-
tions, or chemotherapy or radiation treatments. 
Institutional review boards of all involved 
research institutions, hospitals, and laboratories 
approved the study protocol. All mothers gave 
written informed consent for themselves and 
their children before enrolling. Of 1,263 eli-
gible women, 468 enrolled in the study. Sixty-
seven women dropped out of the study before 
delivery. The remaining 401 women gave birth 
to 389 live singleton babies, as well as 9 sets of 
twins and 3 still-born infants. Of those deliver-
ing singletons, 344 women provided urine at 
both 16 and 26 weeks gestation; they make up 
our primary study sample.
Measurement of pesticide exposure. 
Participants provided blood and spot urine 
samples at 16 and 26 weeks gestation, and 
within 24 hr of delivery. Urine was col-
lected in polypropylene containers and stored 
at –20°C until shipment to the Centers for 
Disease Control and Prevention (CDC) for 
analysis. We measured six urinary DAPs—
dimethylphosphate (DMP), dimethylthio-
phosphate (DMTP), dimethyldithiophosphate 
(DMDTP), diethylphosphate (DEP), diethyl-
thio phosphate (DETP), and diethyldithio-
phosphate (DEDTP), which are common 
metabolites of about 75% of the OP insecti-
cides used in the United States—using a mod-
ification of the analytical method of Bravo 
et al. (2004) that employs gas chromatogra-
phy-tandem mass spectrometry with isotope 
dilution calibration.
Quality control (QC) materials, prepared 
at CDC from spiked pooled urine, were 
analyzed with standards, blanks, and study 
samples. The QC concentrations were evalu-
ated using standard statistical probability rules 
(Caudill et al. 2008). The limits of detection 
(LODs) varied depending on the metabo-
lite and ranged from 0.2 μg/L for DMTP to 
0.6 μg/L for DMP. For samples reporting 
nonzero concentrations below the LOD, we 
used the reported value. We imputed DAP 
concentrations that were reported as zero by 
choosing a random number between zero and 
the lowest nonzero value for that metabolite.
We converted the metabolite concentra-
tions from micrograms per liter to their molar 
concentrations (nanomoles per liter) and 
summed them to obtain overall concentrations 
of diethyl alkyl phosphates (ΣDEAPs: DEP, 
DETP, and DEDTP), dimethyl alkyl phos-
phates (ΣDMAPs: DMP, DMTP, DMDTP), 
and of all six metabolites (ΣDAPs). We used 
creatinine as a marker of urine dilution and 
obtained creatinine-standardized DAP con-
centrations by dividing metabolite concen-
trations by creatinine concentration (Larsen 
1972). To avoid confounding due to met-
abolic changes that occur around the time 
of delivery, we confined our analysis to the 
16- and 26-week results, and restricted the 
analysis to mothers with data from both time 
points. Because metabolite concentrations var-
ied widely between time points, we averaged 
the concentrations of each metabolite across 
the two samples. Because the distribution of 
the averaged DAP concentrations was right-
skewed, we log10-transformed the averages to 
achieve a more normal distribution.
Outcome and covariate measures. We 
abstracted birth weight from medical records, 
and calculated gestational age from the 
 mother’s self-reported date of last menstrual 
period. When this information was not avail-
able, we used the results of an ultrasound 
(n = 7) or a Ballard examination performed 
just after delivery (n = 3) to determine gesta-
tional age. Demographic factors (i.e., maternal 
age, education, race/ethnicity, parity, income, 
marital status) were obtained from subject 
interviews. We also characterized infant size 
using race-specific birth weight for gestational 
age z-scores (e.g., birth weight standardized for 
gestational age) to determine whether infants’ 
growth was restricted relative to their length of 
gestation (Oken et al. 2003).
We measured serum cotinine, a metab-
olite of nicotine that has been validated as a 
biomarker of secondhand and active tobacco 
smoke exposure (Benowitz et al. 2009; 
DeLorenze et al. 2002), and whole blood lead 
concentrations from blood samples taken at the 
same time as the spot urine samples. As with 
the urinary DAP concentrations, we averaged 
serum cotinine and blood lead concentrations 
across the 16- and 26-week samples and log10-
transformed the results. Several women were 
missing lead or cotinine measurements for one 
or both time points; if a lead or cotinine mea-
surement was missing for one time point, we 
used the value for the other time point instead 
of the average. Participants who were missing 
blood lead or serum cotinine concentrations 
from both time points (n = 18) were excluded 
from the analysis. Blood lead and serum coti-
nine were quantified using previously described 
methods at the CDC laboratories (Bernert 
et al. 2000; CDC 2003).
PON genotyping data.  DNA was 
extracted from frozen archived cord blood 
using the 5PRIME PerfectPure DNA blood 
kit (5PRIME, Gaithersburg, MD, USA). 
Genotyping was conducted at the Cincinnati 
Children’s Hospital Medical Center DNA 
sequencing and genotyping core facility. We 
used the Applied Biosystems predesigned 
TaqMan assays (Applied Biosystems, Carlsbad, 
CA, USA) for rs662 (192Q/R) and rs705379 
(–108C/T) with 15 ng of genomic DNA. The 
protocol was as per the manufacturer’s recom-
mendations in 384 well format, including 16 
blanks and 4 sets of 2 controls for QC pur-
poses. Assay plates mixing reagents and DNA 
were prepared using a TECAN Evo200 robotic 
laboratory workstation (TECAN, Durham, 
NC, USA) and amplified in an ABI 9700 ther-
mocycler (Applied Biosystems). TaqMan results 
were read on an ABI 7900HT real time PCR 
system and exported in Excel format using the 
ABI SDS 2.4 software (Applied Biosystems). 
Genotype data was available for 312 of 344 
(90.7%) of infants, with 300 (87.2%) having 
identifiable SNPs at both PON1 sites.
Statistical analysis. For multivariable anal-
ysis, we used PROC GLM in SAS version 
9.1 (SAS Institute Inc., Cary, NC, USA). We 
began with an a priori set of covariates that 
have been consistently associated with ges-
tational age and birth weight: maternal age, 
education, race/ethnicity, and marital status; 
household income; gestational age at initia-
tion of prenatal care; and parity. We also con-
sidered the following covariates: depressive 
symptoms (measured by the Beck Depression 
Inventory-II) (Beck et al. 1996), IQ, insurance 
status, area of residence, maternal body mass 
index, alcohol use during pregnancy, child 
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sex, tobacco exposure (assessed using serum 
cotinine), and blood lead concentrations. Any 
of these covariates showing univariate associa-
tions (p < 0.2) with both DAP concentrations 
and birth outcomes were included in our mul-
tivariable analyses. Only blood lead and serum 
cotinine concentrations fit these  criteria. Our 
final model included maternal age (continu-
ous), race/ethnicity (black or white), and mari-
tal status (married or not married), household 
income (contiuous), parity (0, 1, or ≥ 2), and 
blood lead and serum cotinine concentra-
tions (log10- transformed). We did not include 
gestational age in the primary birth weight 
analysis because of its potentially being on 
the causal pathway. However, for comparison 
with prior results in other cohorts, we con-
structed gestational age-adjusted models in a 
sensitivity analysis.
We assessed the form of the exposure–
response relationship using locally weighted 
regression (LOESS) plots of log-transformed 
concentrations and outcomes. Because a 
straight line fit inside the 95% confidence 
bands, we concluded that it was appropriate to 
use a linear term to describe the relationship.
Based on our preliminary analyses, we 
observed that the pattern for associations 
of DAP concentrations and birth outcomes 
varied by race/ethnicity. Because almost all 
mothers identified themselves as either black 
or white (the “other” group contained only 
15 mothers), we restricted our analyses to 
black and white mothers. We then ran race-
stratified models to obtain effect estimates, 
and formally assessed interactions in separate 
models using cross-product terms between 
race and urinary OP pesticide metabolite con-
centrations, using p < 0.1 as the criteria for a 
statistically significant interaction.
To examine gene–environment inter-
actions between PON1 genotype and OP pes-
ticides, we ran several PON-stratified analyses, 
stratifying by PON1192 or PON1–108. We also 
formally assessed interactions using dummy 
variables and interaction terms. Because race 
appeared to be an effect modifier and PON1 
genotype can vary across racial groups, we also 
ran the PON1-stratified analyses separately for 
black and white mothers whenever possible 
given sample sizes.
We also performed several sensitivity 
analyses. First, we examined whether moth-
ers’ pregnancy medical conditions might 
confound the relationship between urinary 
DAP concentrations and birth outcomes. 
These included abruptio placenta, placenta 
previa, chorioamnionitis, preeclampsia, and 
 pregnancy-induced hypertension. Next, we 
examined whether relationships between 
DAP concentrations and birth weight were 
evident for only term newborns (≥ 37 weeks) 
(Wilcox 2006). We considered child sex as 
an effect modifier and assessed interactions 
with cross-product terms. Next, we assessed 
whether different methods of creatinine 
adjustment altered our results. We used DAP 
concentrations as our exposure variable with-
out creatinine standardization or adjustment, 
and also ran a model with log10- transformed 
mean urinary creatinine concentrations as a 
covariate, as suggested by Barr et al. (2005). 
We also examined whether dilute urine sam-
ples changed the pattern of our results by 
excluding women who had at least one sample 
with creatinine < 20 mg/dL. Finally, to assess 
the effects of different time periods of sample 
collection, we ran separate models using the 
DAP concentrations in  samples taken at the 
16-week and 26-week visits.
Results
Mothers participating in the study were pre-
dominantly white, 25–35 years old, mar-
ried, and primiparous (Table 1). Household 
income and education varied among the 
women, with the greatest proportion falling 
in the $55,000–$85,000 range, with either 
a high school diploma or bachelor’s degree. 
Relatively few infants were born preterm 
(n = 31, 9.0%) or were low birth weight 
(< 2,500 g, n = 20, 5.8%).
All mothers had detectable levels of at 
least one DMAP metabolite, and at least one 
DEAP metabolite was detected in 92.7% 
of women. The ΣDAP metabolites median 
was 81.3 nmol/L (IQR = 42–220) (Table 1). 
Concentrations were higher at 16 weeks than 
at 26 weeks; however, creatinine-standardized 
DAP concentrations were similar at both 
time points. The two creatinine- standardized 
measurements were weakly correlated 
(r = 0.22). ΣDMAP metabolite concentra-
tions (median = 56.9 nmol/L; IQR = 26–185) 
were considerably higher than those of 
ΣDEAP metabolites (median = 17.7 nmol/L; 
IQR = 8–37). The median blood lead concen-
tration was 0.66 μg/dL (IQR = 0.51–0.87), 
and the median serum cotinine level was 
0.027 ng/mL (IQR = 0.01–0.18). In the final 
models, we dropped one mother because of a 
missing creatinine value, 22 because of missing 
covariate values, and 15 in the “other race” cat-
egory, giving us a final sample size of 306.
PON1 genotype was also associated with 
maternal race/ethnicity in the study sample. 
Infants born to white mothers were more 
likely to have PON1192QQ (51.4% vs. 12.7%) 
and PON1–108CT genotypes (45.7% vs. 
20.0%) than infants born to black mothers. 
Infants with black mothers were more likely 
to have PON1192RR (44.3% vs. 10.4%) and 
PON1–108CC (76.3% vs. 29.8%) genotypes 
(all chi-square p-values < 0.001).
Table 1. Demographic characteristics of HOME study participants: Cincinnati, Ohio, 2003–2006 (n = 344).a
 n (%)
Birth weight (g) 
(mean ± SD)




All participants 344 (100) 3,383 ± 622 39.0 ± 1.7 81.3 (41.7–220.0)
Age (years)
Under 25 72 (21.4) 3,055 ± 619 38.6 ± 2.2 108.1 (55.0–244.2)
25–29.9 96 (28.6) 3,508 ± 576 39.3 ± 1.5 77.9 (41.7–220.0)
30–34.9 111 (33.0) 3,476 ± 573 39.1 ± 1.6 66.7 (39.3–169.8)
35 or Older 57 (17.0) 3,392 ± 682 38.7 ± 1.7 93.7 (46.9–232.2)
Race/ethnicity
Black 97 (28.4) 3,128 ± 539 38.6 ± 1.8 126.5 (44.8–319)
White 229 (67.2) 3,516 ± 602 39.2 ± 1.5 75.2 (41.3–192.3)
Other 15 (4.4) 3,249 ± 648 38.9 ± 2.3 142.6 (73.4–231.6)
Household income
< $22,500 64 (19.2) 3,121 ± 467 38.9 ± 1.5 97.5 (41.7–254.2)
$22,500–$45,000 86 (25.7) 3,432 ± 658 38.9 ± 1.7 101.8 (39.7–245.7)
$55,000–$85,000 117 (35.0) 3,515 ± 634 39.1 ± 1.8 75.0 (36.5–169.8)
> $85,000 67 (20.1) 3,410 ± 561 39.2 ± 1.7 104.2 (52.5–213.7)
Education
Less than high school 32 (9.4) 3,130 ± 533 38.8 ± 1.6 92.4 (41.4–216.5)
High school diploma 129 (37.8) 3,316 ± 581 39.0 ± 1.7 76.1 (36.2–192.7)
Bachelor’s degree 102 (29.9) 3,532 ± 606 39.2 ± 1.6 85.0 (44.1–243.6)
Graduate degree 78 (22.9) 3,451 ± 652 39.0 ± 1.8 91.8 (47.6–219.7)
Marital status
Married 233 (68.3) 3,477 ± 616 39.1 ± 1.7 80.7 (43.6–219.6)
Not married 108 (31.7) 3,215 ± 563 38.9 ± 1.7 90.6 (40.4–239.9)
Parity
0 155 (45.2) 3,342 ± 607 39.3 ± 1.6 99.1 (46.3–234.1)
1 109 (31.8) 3,451 ± 587 39.0 ± 1.5 76.1 (41.9–192.7)
≥ 2 79 (23.0) 3,369 ± 697 38.4 ± 2.1 66.0 (32.6–192.3)
Child sex
Female 181 (52.6) 3,290 ± 572 39.0 ± 1.7 76.1 (39.2–207.4)
Male 163 (47.4) 3,487 ± 660 39.0 ± 1.7 90.2 (46.3–232.2)
25th and 75th are percentiles.
aStudy population included women who provided spot urine samples at the 16-week and 26-week visits.
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In multivariable analysis, a 10-fold 
increase in ΣDAP concentrations, which 
corresponds roughly to a shift from the 
15th (29.5 nmol/L) to the 85th percentile 
(318.0 nmol/L) of the distribution, was asso-
ciated with a 0.5-week decrease in gestational 
age [95% confidence interval (CI): –0.8, 
–0.1] (Table 2). Associations with ΣDEAP 
and ΣDMAP concentrations were weaker, 
but ΣDMAP concentrations were associ-
ated with a 0.4-week decrease in gestational 
length (95% CI: –0.7, 0.0). Birth weight was 
also inversely associated with ΣDAP concen-
trations (–151 g, 95% CI: –287, –16) and 
ΣDMAP concentrations (–124 g, 95% CI: 
–245, –2), but not ΣDEAP concentrations. 
The relationship between ΣDAP concentra-
tions and birth weight was attenuated after 
adjustment for gestational age (–40 g; 95% 
CI: –146, 65).
In race-stratified models, ΣDAP concen-
trations were associated with shortened ges-
tation in white newborns, but not in black 
newborns (Table 2). The interaction between 
ΣDAP concentrations and black race/ethnicity 
in separate cross-product models was signifi-
cant at p = 0.10. In contrast, ΣDAP concen-
trations were associated with a larger decrease 
in birth weight among black newborns than in 
white newborns, although the interaction was 
not statistically significant (p = 0.46). Once 
we adjusted for gestational age, however, we 
observed a slightly weaker but statistically sig-
nificant inverse association between ΣDAP 
concentrations and birth weight for black 
newborns, and the interaction for ΣDAP con-
centrations and birth weight by race/ethnicity 
became statistically significant (p = 0.02). We 
also found a nonsignificant inverse relation-
ship between urinary OP metabolite concen-
trations and birth weight for gestational age 
(–0.18 z-score units; 95% CI: –0.41, 0.06). 
The relationship was stronger among blacks 
(–0.40; 95% CI: –0.73, –0.08) than whites 
(–0.02; 95% CI: –0.33, 0.30).
In PON1-stratified models, we observed 
the strongest associations between ΣDAP con-
centrations and birth weight and gestational 
age in the heterozygous groups: PON1192QR 
and PON1–108CT [see Supplemental Material, 
Table 1 and Figures 1 and 2 (http://dx.doi.
org/10.1289/ehp.1104615)]. Several inter-
action terms between PON1 genotypes and 
ΣDAP concentrations were statistically signifi-
cant. Looking at models stratified by race and 
PON1 status, numbers of observations in many 
of the categories were too small to produce 
stable point estimates. However, in almost all 
cases we observed the strongest associations 
between DAP metabolites and birth outcomes 
appearing in the heterozygous groups. We 
found no evidence for main effects of PON1 
genotype on either birth weight or length of 
gestation (data not shown).
Sensitivity analyses. Medical conditions 
were associated with birth outcomes and DAP 
urinary concentrations (Table 3). Mothers 
who had abruptio placenta (n = 9), placenta 
previa (n = 1), chorioamnionitis (n = 1), pre-
eclampsia (n = 15), or pregnancy-induced 
hypertension (n = 9) had shorter gestations and 
lower-birth-weight newborns than the rest of 
the study population (data not shown). These 
mothers also had higher median DAP urinary 
concentrations than mothers without the con-
ditions (Table 3), although we did not perform 
formal statistical tests because of small sample 
sizes. Generally, the magnitude of association 
between ΣDAP concentrations and gestational 
age was similar when we excluded observations 
based on various combinations of the medical 
conditions. The point estimates for birth weight 
ranged from –168 g (95% CI: –307, –28) 
when women with hypertension were excluded 
to –111 g (CI: –248, 26) when women with 
placental conditions, chorioamnionitis, or 
hypertension were all excluded (all estimates 
reported for sensitivity analyses are adjusted for 
the same covariates as in the primary analysis, 
unless otherwise noted).
Restricting analyses to full-term births 
(≥ 37 weeks gestation, n = 282) attenuated 
the effect estimates for a 10-fold increase in 
ΣDAP concentrations for both gestational age 
(–0.2 weeks, 95% CI: –0.4, 0.0) and birth 
weight (–88 g, 95% CI: –213, 37), but the pat-
terns were consistent with our primary results. 
Stratifying full-term births by race produced 
results that were similar to those for preterm 
and term births combined: Associations with 
birth weight were stronger among black new-
borns than white newborns, whereas estimated 
effects for gestational age were stronger in white 
newborns than black newborns. We did not 
find any suggestion of an interaction between 
child sex and ΣDAP concentrations for either 
gestational age or birth weight (p > 0.3).
Using non-creatinine-standardized 
ΣDAP concentrations modestly attenuated 
the observed estimates: In the full group, the 
gestational age coefficient was –0.3 weeks 
(95% CI: –0.7, 0.0) and the birth weight 
coefficient was –100 g (95% CI: –232, 32). 
Adjusted coefficients in all secondary analy-
ses were closer to the null without creatinine 
adjustment, but the pattern with respect to race 
remained the same (data not shown). Likewise, 
excluding women with urinary creatinine values 
< 20 mg/dL (n = 37) did not change the pattern 
of results (data not shown). Finally, associations 
obtained when using ΣDAP concentrations 
from individual spot urine collections were 
slightly attenuated compared with the average 
of the 16- and 26-week collections, for both 
the 16-week (gestational age: β = –0.2 weeks, 
95% CI: –0.6, 0.1; birth weight: β = –110g, 
95% CI: –221, 1) and 26-week samples (gesta-
tional age: β = –0.3 weeks, 95% CI: –0.6, 0.0; 
birth weight: β = –88g, 95% CI: –208, 33).
Table 2. Mean change in gestational length and birth weight associated with a 10-fold increase in average urinary DAP concentrations (nmol/L) among white 
and black mothers.
OP Metabolitea
Length of gestation (weeks)b Birth weight (g)b Birth weight, adjusted for gestational age (g)c
β (95% CI) p-value p interactiond β (95% CI) p-value p interactiond β (95% CI) p-value p interactiond
All mothers (n = 306)
ΣDAP –0.5 (–0.8, –0.1) 0.01 NA –151 (–287, –16) 0.03 NA –40 (–146, 65) 0.45 NA
ΣDEAP –0.2 (–0.5, 0.1) 0.14 –65 (–180, 51) 0.27 –9 (–99, 80) 0.83
ΣDMAP –0.4 (–0.7, 0.0) 0.03 –124 (–245, –2) 0.05 –38 (–133, 56) 0.43
Black mothers (n = 93)
ΣDAP –0.1 (–0.9, 0.6) 0.69 0.10 –188 (–395, 19) 0.07 0.46 –158 (–297, –18) 0.03 0.02
ΣDEAP –0.1 (–0.8, 0.5) 0.64 0.47 –162 (–340, 16) 0.07 0.39 –131 (–251, –11) 0.03 0.08
ΣDMAP 0.0 (–0.7, 0.6) 0.97 0.09 –142 (–333, 50) 0.15 0.46 –139 (–267, –10) 0.03 0.02
White mothers (n = 213)
ΣDAP –0.7 (–1.1, –0.3) < 0.01 NA –118 (–296, 60) 0.19 NA 60 (–84, 204) 0.41 NA
ΣDEAP –0.3 (–0.7, 0.0) 0.09 –39 (–189, 111) 0.61 41 (–78, 160) 0.5
ΣDMAP –0.6 (–0.9, –0.2) < 0.01 –96 (–254, 62) 0.23 49 (–78, 177) 0.45
NA, not applicable. Excludes mothers in the “other race” category (n = 15) and with missing covariate information (n = 23). A 10-fold increase in total DAP concentrations (i.e., a 1-unit 
increase in log10-transformed concentrations) corresponds roughly to an increase from the 15th (29.5 nmol/L) to the 85th percentile (318.0 nmol/L) of the distribution.
aMetabolites are log10-transformed and creatinine-standardized. bAdjusted for mother’s age, household income, marital status, parity category, and log10-transformed blood lead and 
log10-transformed cotinine. Models including black and white mothers are also adjusted for maternal race. cAdditional adjustment for gestational age. dp-Value for race × exposure 
interaction term from separate cross-product models.
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Discussion
We found that maternal exposure to OP insec-
ticides, assessed by measuring urinary OP 
pesticide metabolites, was inversely associated 
with gestational age and birth weight. The esti-
mated effects of OP exposure differed by race: 
Gestational age was inversely associated with 
DAP concentrations in white, but not black 
mothers. In contrast, we observed a stronger 
inverse association between maternal DAP 
concentrations and birth weight among black 
newborns than white newborns. The same pat-
tern persisted when we restricted the analysis 
to full-term newborns, although the associa-
tions were attenuated. Although we chose not 
to adjust for gestational age in the primary 
analysis because it is may be on the causal path-
way, our results in white mothers are consistent 
with those of Eskenazi et al. (2004), who found 
that higher urinary ΣDMAP concentrations 
were associated with shortened gestation and 
small increases in gestational age–adjusted birth 
weight in a primarily Latina cohort. The results 
for the association of OP insecticides and birth 
weight for gestational age z-scores closely mir-
rored our results for birth weight adjusted for 
gestational age. Again, we found an association 
for black, but not white, infants. In addition, 
at 39 weeks gestation (the study population 
mean) the estimated z-score decrease of 0.4 
associated with a 10-fold increase in ΣDAPs 
corresponds to a decrease of about 160 g (Oken 
et al. 2003). Although others have reported 
effect modification by child sex (Marks et al. 
2010), we found no evidence of an interaction. 
It is possible that different levels of exposure 
could affect the results; however, we observed 
ΣDAP concentrations (median = 81.3 nmol/L) 
comparable to the urban population in the 
Mount Sinai birth cohort in New York City 
(median = 75.9 nmol/L) (Wolff et al. 2007) 
and lower than those in the agricultural popu-
lation of the CHAMACOS cohort (median 
= 136 nmol/L) (Eskenazi et al. 2004). The 
Columbia University birth cohort used serum 
chlorpyrifos to categorize OP exposure, and was 
not directly comparable (Whyatt et al. 2004).
It is unclear why OP insecticides would 
be associated with shorter gestation in white 
newborns, but not black newborns. Although 
black mothers had higher levels of urinary 
OP pesticide metabolites than white mothers, 
these metabolites are a nonspecific measure of 
exposure to various OP insecticides; different 
OP pesticides may act through a variety of 
mechanisms, some affecting length of gestation 
and others affecting fetal growth. Blacks and 
whites might differentially be exposed to these 
different formulations of pesticides. Maternal 
race/ethnicity may also be acting as a proxy for 
a combination of conditions—socioeconomic 
factors, genetic susceptibility, psychological 
stressors, and environmental toxicants—only 
some of which were measured in our study. 
We examined several possible confounders, 
including income, education, maternal depres-
sive symptoms, maternal IQ, insurance sta-
tus, area of residence, prenatal care, PON1 
genotype, and gestational exposure to alcohol, 
lead, and tobacco; however there may be other 
factors we did not measure. Like Davis et al. 
(2009), we found racial differences in the dis-
tribution of PON1 genotypes; however, the 
race/ethnicity interactions were not affected 
when we adjusted for PON1 genotype (data 
not shown).
Excluding mothers with specific medical 
conditions, especially those who had placental 
abnormalities or chorioamnionitis, attenu-
ated the association of urinary DAP concen-
trations and perinatal outcomes. Excluding 
women with hypertensive conditions, which 
were more common in black mothers than in 
white mothers, strengthened the associations 
to a negligible extent.
For both PON1 polymorphisms we exam-
ined, the heterozygous groups (PON1192QR 
and PON1–108CT) generally showed the largest 
estimated decreases in birth weight and gesta-
tional length associated with log10-transformed 
ΣDAP concentrations. These results were unex-
pected, but > 200 polymorphisms of PON1 
have been identified, and it may be unreason-
able to expect two PON1 polymorphisms to 
explain the amount of PON produced or its 
efficiency in detoxifying certain chemicals 
(Costa et al. 2005, 2011). Several studies look-
ing for OP–PON1 interactions have measured 
not only genotype, but PON enzyme activity 
as well (Harley et al. 2011; Wolff et al. 2007). 
We did not measure serum levels of PON and 
other OP-detoxifying enzymes, or maternal 
PON1 genotype, which may be more relevant 
during gestation and fetal development. It is 
also worth noting that studies on PON1 have 
focused on pesticides such as chlorpyrifos, diaz-
inon, and parathion, which metabolize into 
DEP and DETP, whereas other OPs such as 
malathion, azinphos methyl, and dimethoate 
metabolize into DMP and DMTP (Maroni 
et al. 2000). DMAP metabolites were much 
more abundant in our study samples, and their 
associations were typically stronger than the 
DEAP metabolite associations. It is possible 
that PON1 polymorphisms act differently on 
DEAP- and DMAP-producing OPs.
This study has several strengths and limita-
tions, primarily related to using urinary DAP 
metabolites as a marker of OP insecticide expo-
sure. Urinary DAP measurements reflect expo-
sure to nontoxic preformed metabolites as well 
as the parent (toxic) OP pesticides, particularly 
for dietary exposures (Lu et al. 2005). Urinary 
DAPs have a half-life < 24 hr in humans, so 
their urinary concentrations reflect only recent 
exposure (Barr and Angerer 2006). The combi-
nation of the short elimination half-life and the 
episodic nature of exposures to OP pesticides 
results in a high degree of variability in uri-
nary DAP concentrations. We were also unable 
to rule out the possibility that differences in 
DAP concentrations partially reflect individual 
variation in metabolism. One strength of this 
study, however, is that we were able to account 
for some of the temporal variation in urinary 
DAP concentrations by combining the con-
centrations of two samples taken months apart. 
Although there may still have been some degree 
of exposure misclassification, it was most likely 
nondifferential, and would tend to bias our 
results towards the null. Another limitation 
is that, unlike serum measures of the OP pes-
ticide, which are often undetectable, urinary 
DAP concentrations cannot quantify exposure 
to a particular parent pesticide, although the 
class of metabolites (DEAP vs. DMAP) can 
suggest exposure to certain groups of OP pesti-
cides. The ability to identify specific OP expo-
sures would improve etiological studies because 
OPs differ widely in their uses and relative 
Table 3. Median ΣDAP concentration in mothers with and without selected medical conditions and mean change in gestational length and birth weight associ-
ated with a 10-fold increase in average urinary ΣDAP concentrations after exclusion based on medical conditions.
Median ΣDAP concentration 
(nmol/L) (25th–75th) Gestational age (weeks)a Birth weight (g)a
Birth weight, adjusted for 
gestational age (g)b
Condition n With condition Without condition β (95% CI) p -value β (95% CI) p -value β (95% CI) p -value
None 306 NA 77.9 (41.6–207.4) –0.5 (–0.8, –0.1) 0.01 –151 (–287, –16) 0.03 –40 (–146, 65) 0.45
Placental/chorio 296 133.3 (82.7–192.7) 76.1 (41.2–210.6) –0.3 (–0.6, 0.0) 0.08 –115 (–245, 15) 0.08 –48 (–154, 59) 0.38
Hypertensive 288 110.3 (63.8–190.9) 76.2 (41.4–210.5) –0.6 (–0.9, –0.2) < 0.01 –168 (–307, –28) 0.02 –30 (–143, 83) 0.60
Placental/chorio and hypertensive 282 128.3 (64.8–237.1) 75.7 (41.1–207.4) –0.3 (–0.7, 0.0) 0.06 –111 (–248, 26) 0.11 –33 (–145, 79) 0.56
NA, not applicable. 25th and 75th are percentiles. Excludes 15 mothers in “other race” category and 23 with missing covariate information. “Placental/chorio” (n = 10) includes 
8  mothers with abruptio placenta, 1 with abruption placenta and placenta previa, and 1 with chorioamnionitis. “Hypertensive” (n = 18) includes 9 mothers with preeclampsia, 3 mothers 
with pregnancy-induced hypertension, and 6 mothers with preeclampsia and pregnancy-induced hypertension. Four mothers had preeclampsia and hypertensive conditions.
aAdjusted for mother’s age, race, household income, marital status, parity category, and log10-transformed blood lead and log10-transformed cotinine. bAdditional adjustment for 
 gestational age.
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toxicity. Similarly, we were unable to pinpoint 
the dominant sources of exposure to OP pesti-
cides. Diet and home pesticide use have been 
identified as important routes of exposure in 
nonagricultural populations, although Lu et al. 
(2008) found that switching children from 
conventional to organic diets for several days 
reduced urinary OP metabolites to levels near 
or below the limit of detection, suggesting that 
diet was the primary source of exposure in that 
study population. Even if we were able to iso-
late a particular pesticide, it would be difficult 
to connect it to a particular route of exposure, 
as many different pesticides are used in agricul-
ture, as well as in and around the home.
The reliance on self-reported dates of last 
menstrual period to determine gestational 
age represents another limitation (Lynch and 
Zhang 2007). This method is imprecise; how-
ever, there is no reason to suspect differen-
tial misclassification of gestational age with 
respect to OP exposure. In addition, it was 
recorded more consistently (97% of mothers) 
than was ultrasound (8%). Finally, informa-
tion on PON enzyme activity or maternal 
PON1 status might shed more light on PON-
mediated susceptibility than infant PON1 
genotypes alone. Other strengths of this study 
are that we presented data from a racially and 
demographically mixed birth cohort in a sam-
ple, intentionally enriched with black women, 
from the Cincinnati metropolitan area. We 
also controlled for a wide range of confound-
ers, including continuous measures of lead 
and tobacco exposure, and pregnancy medical 
complications, and our findings were robust 
to several sensitivity analyses.
Conclusion
Prenatal OP insecticide exposure was associated 
with shorter gestation and lower birth weight 
in this cohort. The magnitude of these associa-
tions differed according to maternal race and 
infant PON1 genotype status. Although the 
prior literature on gestational OP exposure and 
birth outcomes is inconclusive, several studies 
have observed associations between adverse 
health outcomes in children and maternal 
exposure to OP insecticides during gestation, 
including abnormal reflexes (Engel et al. 2007), 
reduced cognitive abilities (Bouchard et al. 
2011; Engel et al. 2011; Rauh et al. 2011), and 
ADHD and attention problems (Bouchard 
et al. 2010; Marks et al. 2010). Although OP 
insecticide use in the United States has declined 
in recent years (Grube et al. 2011), exposures 
to them remain widespread. These results are 
not definitive, but they serve to remind us 
about Rachel Carson’s warnings about the use 
of chemicals of uncertain  toxicity, including 
OP insecticides.
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